is d vax L the only dendritic cancer vaccine with the phase 3 data necessary to get RA approval with the 20 largest regulatory authorities in the next 10 years ?
DCVax is the most crucial cell-based vaccine. Indeed, #DCVax has enabled personalized targeting of several tumor antigens to achieve a potentially durable response.
Market Data 
Markets 
AI
